User Tools

Site Tools


keynote001

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
keynote001 [2023/02/08 00:27] gilbertkeynote001 [2025/02/01 17:00] (current) – external edit 127.0.0.1
Line 1: Line 1:
-===== The 2015 KEYNOTE-001 Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer =====+===== The 2015 KEYNOTE-001 clinical trial for the Treatment of NSCLC using Pembrolizumab ===== 
 +https://www.nejm.org/doi/full/10.1056/nejmoa1501824 
 + 
 +{{ :pdl1-nsclc.jpg?nolink |}} 
 {{ ::oskeynote001.jpg?nolink |}} {{ ::oskeynote001.jpg?nolink |}}
 +
 +{{ ::oldladycci.jpg?nolink |}}
  
 ===== The 2015 KEYNOTE-001 Adverse Effects ===== ===== The 2015 KEYNOTE-001 Adverse Effects =====
  
 {{ ::adverse.jpg?nolink |}} {{ ::adverse.jpg?nolink |}}
keynote001.1675841249.txt.gz · Last modified: 2025/02/01 17:00 (external edit)

Donate Powered by PHP Valid HTML5 Valid CSS Driven by DokuWiki